Serum markers of brain-cell damage and C-reactive protein are unaffected by electroconvulsive therapy

World Journal of Biological Psychiatry

Volumn 9, Issue 3, 2008, Pages 231-235

  Giltay, Erik J ^a   Kho, King H ^a   Blansjaar, Ben A ^a  

^a GGZ Delfland   (Netherlands)

Author keywords

Brain damage; C reactive protein; Electroconvulsive therapy; Humans; Prolactin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIDEPRESSANT AGENT; ASPARTATE AMINOTRANSFERASE; BENZODIAZEPINE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CELL ENZYME; CREATINE KINASE; CREATINE KINASE BB; CREATINE KINASE MB; LACTATE DEHYDROGENASE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PROLACTIN;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; BRAIN CELL; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MALE; PROTEIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BRAIN DAMAGE, CHRONIC; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; PROLACTIN;

EID: 48249084873     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701310989     Document Type: Article

References (23)

1. Agelink, MW, Andrich, J. Postert, T. et al. (2001) Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. 71, pp. 394-396.
2. Berrouschot, J., Rolle, K., Kuhn, HJ and Schneider, D. (1997) Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. 150, pp. 173-176.
3. Braasch, ER and Demaso, DR. (1980) Effect of electroconvulsive therapy on serum isoenzymes. 137, pp. 625-626.
4. Coffey, CE, Weiner, RD Djang, WT et al. (1991) Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. 48, pp. 1013-1021.
5. Dec Jr, GW, Stern, TA and Welch, C. (1985) The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients. 253, pp. 2525-2529.
6. Devanand, DP, Dwork, AJ, Hutchinson, ER, Bolwig, TG and Sackeim, HA. (1994) Does ECT alter brain structure?. 151, pp. 957-970.
7. Greffe, J., Lemoine, P. Lacroix, C. et al. (1996) Increased serum levels of neuron-specific enolase in epileptic patients and after electroconvulsive therapy - a preliminary report. 244, pp. 199-208.
8. Helzberg, JH and Spiro, HM. (1986) "LFTs" test more than the liver. 256, pp. 3006-3007.
9. Hoyle, NR, Pratt, RT and Thomas, DG. (1984) Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity. 288, pp. 1110-1111.
10. Jacobs, DS, Demott, WR, Finley, PR, Horvat, RT, Kasten, BLJ and Tilzer, LL. (1994) Lexi-Comp Inc, Hudson, (Cleveland)
11. Lisanby, SH, Devanand, DP Prudic, J. et al. (1998) Prolactin response to electroconvulsive therapy: Effects of electrode placement and stimulus dosage. 43, pp. 146-155.
12. Lott, JA, Pappas, TN, Stang, JM, Pitts, C. and Knopp, W. (1982) Electroconvulsive therapy does not change serum CK, LD, or LD isoenzymes. 43, pp. 169-170.
13. Ohaeri, JU, Hedo, CC, Enyidah, SN and Ogunniyi, AO. (1992) Tissue injury-inducing potential of unmodified ECT: Serial measurement of acute phase reactants. 8, pp. 253-257.
14. Pelsers, MM, Hanhoff, T. Van der Voort, D. et al. (2004) Brain- and heart-type fatty acid-binding proteins in the brain: Tissue distribution and clinical utility. 50, pp. 1568-1575.
15. Raison, CL, Capuron, L. and Miller, AH. (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. 27, pp. 24-31.
16. Sackeim, HA, Prudic, J. Devanand, DP et al. (2000) A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. 57, pp. 425-434.
17. Schiepers, OJ, Wichers, MC and Maes, M. (2005) Cytokines and major depression. 29, pp. 201-217.
18. Tew Jr, JD, Mulsant, BH Haskett, RF et al. (1999) Acute efficacy of ECT in the treatment of major depression in the old- old. 156, pp. 1865-1870.
19. The UK ECT Review Group (2003) Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis.361, pp. 799-808.
20. van Waarde, JA and Stek, ML. (2001) [Electroconvulsive therapy effective and safe in 55 patients aged 56 years and older with mood disorders and physical comorbidity]. 145, pp. 1693-1697.
21. Vigushin, DM, Pepys, MB and Hawkins, PN. (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. 90, pp. 1351-1357.
22. Webb, MG, O'Donnell, MP, Draper, RJ, Horner, B. and Phillips, JP. (1984) Brain-type creatine phosphokinase serum levels before and after ECT. 144, pp. 525-528.
23. Zachrisson, OC, Balldin, J. Ekman, R. et al. (2000) No evident neuronal damage after electroconvulsive therapy. 96, pp. 57-165.